Insight Holdings Group, Llc Sells 112,477 Shares of Hinge Health (NYSE:HNGE) Stock

Hinge Health Inc. (NYSE:HNGE) major shareholder Insight Holdings Group, Llc sold 112,477 shares of Hinge Health stock in a transaction that occurred on Tuesday, June 23rd. The stock was sold at an average price of $70.21, for a total value of $7,897,010.17. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Insight Holdings Group, Llc also recently made the following trade(s):

• On Wednesday, June 24th, Insight Holdings Group, Llc sold 142,311 shares of Hinge Health stock. The shares were sold at an average price of $71.67, for a total value of $10,199,429.37.
• On Wednesday, June 24th, Insight Holdings Group, Llc sold 390,917 shares of Hinge Health stock. The stock was sold at an average price of $71.15, for a total value of $27,813,744.55.
• On Monday, June 22nd, Insight Holdings Group, Llc sold 224,399 shares of Hinge Health stock. The stock was sold at an average price of $70.95, for a total value of $15,921,109.05.
• On Tuesday, June 16th, Insight Holdings Group, Llc sold 65,581 shares of Hinge Health stock. The stock was sold at an average price of $70.36, for a total transaction of $4,614,279.16.

Hinge Health Stock Up 6.1%

HNGE stock opened at $74.86 on Friday. Hinge Health Inc. has a twelve month low of $30.08 and a twelve month high of $75.17. The stock has a market capitalization of $5.79 billion and a price-to-earnings ratio of -6.07. The firm’s fifty day simple moving average is $56.17 and its two-hundred day simple moving average is $47.33.

Hinge Health (NYSE:HNGE) last released its earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.12 by $0.33. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 310.62%. The firm had revenue of $182.31 million during the quarter. During the same quarter last year, the business posted $1.30 EPS. Hinge Health’s revenue was up 47.2% compared to the same quarter last year. As a group, equities research analysts expect that Hinge Health Inc. will post 1.33 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on HNGE. KeyCorp boosted their target price on Hinge Health from $75.00 to $90.00 and gave the company an “overweight” rating in a research report on Friday, June 12th. Robert W. Baird raised their price target on Hinge Health from $55.00 to $65.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 17th. Canaccord Genuity Group boosted their price objective on Hinge Health from $65.00 to $76.00 and gave the company a “buy” rating in a report on Monday, June 15th. Weiss Ratings raised Hinge Health from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 6th. Finally, Truist Financial increased their target price on Hinge Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research note on Thursday, June 11th. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Hinge Health currently has a consensus rating of “Moderate Buy” and an average target price of $75.80.

Trending Headlines about Hinge Health

Here are the key news stories impacting Hinge Health this week:

• Positive Sentiment: Hinge Health raised its Q2 2026 revenue guidance to $200 million-$202 million, above the Street’s $195 million estimate, and lifted full-year 2026 revenue guidance to $818 million-$824 million versus consensus of $801.6 million, signaling better-than-expected growth momentum.
• Positive Sentiment: Recent operating results remain strong, with the company’s last reported quarter showing 47.2% revenue growth and earnings that beat analyst expectations, helping support bullish sentiment around the stock.
• Neutral Sentiment: Wall Street remains broadly constructive on Hinge Health, with recent analyst price targets ranging from the high-$70s to $90 and a consensus rating of Moderate Buy, suggesting investors still see upside potential.
• Negative Sentiment: Insight Holdings Group, a major shareholder, sold multiple large blocks of HNGE shares in recent days, including transactions on June 22, June 23, and June 24. Although the sales were made under a pre-arranged Rule 10b5-1 plan, the volume of selling may pressure sentiment. SEC filing
• Negative Sentiment: President James Pursley also sold 33,000 shares, adding to the cluster of insider sales and raising questions about valuation after the stock’s recent run-up. SEC filing

Institutional Trading of Hinge Health

A number of hedge funds have recently added to or reduced their stakes in HNGE. Wells Fargo & Company MN grew its holdings in Hinge Health by 160.0% during the 4th quarter. Wells Fargo & Company MN now owns 546 shares of the company’s stock worth $25,000 after acquiring an additional 336 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new stake in shares of Hinge Health in the 4th quarter valued at about $26,000. First Horizon Corp lifted its position in shares of Hinge Health by 163.9% in the 4th quarter. First Horizon Corp now owns 855 shares of the company’s stock worth $40,000 after purchasing an additional 531 shares during the period. CENTRAL TRUST Co bought a new position in shares of Hinge Health during the first quarter valued at approximately $37,000. Finally, Aster Capital Management DIFC Ltd bought a new position in shares of Hinge Health during the third quarter valued at approximately $49,000.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.